Securing diagnostic accuracy in HIV-cryptococcus co-infection: the power of clinical microbiology
DOI:
https://doi.org/10.18203/2320-6012.ijrms20264262Keywords:
Cryptococcal meningitis, HIV, Cryptococcus spp, India ink, Fungal culture, Opportunistic infectionAbstract
Cryptococcal meningitis is a life-threatening opportunistic fungal infection in patients with advanced HIV infection. Early diagnosis is essential to reduce morbidity and mortality. Conventional microbiological techniques remain valuable, particularly in resource-limited settings. A 40-year-old male with a three-year history of HIV infection and irregular antiretroviral therapy presented with a two-week history of progressively worsening headache, low-grade fever, nausea, vomiting, photophobia, blurred vision, and altered sensorium. Cerebrospinal fluid (CSF) examination revealed markedly elevated opening pressure, lymphocytic pleocytosis, elevated protein, and reduced glucose. India ink examination demonstrated encapsulated, budding yeast cells. Gram staining revealed round, budding yeast cells, while fungal culture on Sabouraud dextrose agar yielded creamy, mucoid colonies. The isolate was urease-positive, and bacterial cultures were negative. Based on the clinical presentation and conventional microbiological findings, a diagnosis of cryptococcal meningitis was established. The patient received induction therapy with liposomal amphotericin B and flucytosine, followed by planned consolidation therapy with fluconazole. This case highlights the importance of considering cryptococcal meningitis in HIV-positive patients presenting with subacute headache and fever. A systematic approach combining clinical assessment, CSF examination, India ink staining, fungal culture, and urease testing can facilitate diagnosis in routine microbiology laboratories, particularly where advanced diagnostic facilities are unavailable.
References
Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022;22(12):1748-55.
Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873-81.
Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am ClinClimatol Assoc. 2013;124:61-79.
Patel AK, Patel KK, Ranjan R, Shah S, Patel JK. Management of cryptococcal meningitis in HIV-infected patients: experience from western India. Indian J Sex Transm Dis AIDS. 2010;31(1):22-6.
Kumar S, Wanchu A, Chakrabarti A, Sharma A, Bambery P, Singh S. Cryptococcal meningitis in HIV infected: experience from a North Indian tertiary center. Neurol India. 2008;56(4):444-9.
Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179-206.
Chang CC, Harrison TS, Bicanic TA, Chayakulkeeree M, Sorrell TC, Warris A, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024;24(8):e495-512.
World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Geneva: World Health Organization. 2022. Available at: https://www.who.int/publications/i/item/9789240052178. Accessed on 3 July 2026.
Vedpathak MU, Shaikh NK, Shaikh NA, Kandle SK. Cryptococcal meningitis: a delineating presentation peeping toward HIV status. Indian J Case Rep. 2020;6(12):709-11.
Srinivasan J, Singh N, Anam N, Wagh S, Sharma S. Cryptococcal meningitis in a human immunodeficiency virus sero-positive patient: a case study. Eur J Ther. 2023;29(3):681-5.
Hathiwala R, Wankhade AB, Dhandale P. Cryptococcal meningitis in an immunocompetent patient-missed diagnosis: a case report. J Microbiol Exp. 2018;6(2):117-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ankita P. Chawla Chawla, Rupali S. Mantri, Nazneen I. Malak, Saahil Parvez

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.